Eliana Merle
Stock Analyst at UBS
(1.85)
# 2,980
Out of 4,829 analysts
80
Total ratings
30%
Success rate
-6.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintains: Buy | $78 → $70 | $24.25 | +188.66% | 7 | May 2, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $441 → $458 | $299.69 | +52.82% | 4 | May 2, 2025 | |
| CVAC CureVac | Maintains: Buy | $13 → $12 | $3.49 | +243.84% | 2 | Apr 30, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Buy | $65 → $72 | $34.17 | +110.71% | 3 | Apr 30, 2025 | |
| APLS Apellis Pharmaceuticals | Initiates: Overweight | $44 | $17.30 | +154.34% | 8 | Apr 29, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $109 → $113 | $58.86 | +91.98% | 2 | Feb 20, 2025 | |
| ETNB 89bio | Maintains: Buy | $25 → $38 | $7.71 | +393.19% | 3 | Jan 31, 2025 | |
| AKRO Akero Therapeutics | Maintains: Buy | $42 → $109 | $39.85 | +173.53% | 4 | Jan 31, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Neutral | $5 → $2.2 | $1.23 | +78.86% | 4 | Jan 28, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $65 → $71 | $40.42 | +75.66% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $196 | $151.46 | +29.41% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.10 | +177.23% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.26 | +268.10% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $3 | $3.62 | -17.13% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $5.59 | +365.12% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $74 | $30.07 | +146.09% | 2 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $23 → $33 | $19.62 | +68.20% | 4 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $97 → $131 | $92.87 | +41.06% | 6 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $2 | $0.75 | +165.43% | 2 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $253 → $288 | $251.15 | +14.67% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $5 | $3.77 | +32.63% | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $18 | $3.04 | +492.11% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $42 | $12.79 | +228.38% | 4 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $8 | $1.11 | +620.72% | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $4.09 | +437.90% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $47 | $7.52 | +525.00% | 1 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.99 | +167.34% | 2 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $123 | $6.61 | +1,760.82% | 3 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $192 → $134 | $25.31 | +429.44% | 3 | Aug 19, 2020 |
Moderna
May 2, 2025
Maintains: Buy
Price Target: $78 → $70
Current: $24.25
Upside: +188.66%
Madrigal Pharmaceuticals
May 2, 2025
Maintains: Buy
Price Target: $441 → $458
Current: $299.69
Upside: +52.82%
CureVac
Apr 30, 2025
Maintains: Buy
Price Target: $13 → $12
Current: $3.49
Upside: +243.84%
BridgeBio Pharma
Apr 30, 2025
Maintains: Buy
Price Target: $65 → $72
Current: $34.17
Upside: +110.71%
Apellis Pharmaceuticals
Apr 29, 2025
Initiates: Overweight
Price Target: $44
Current: $17.30
Upside: +154.34%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Buy
Price Target: $109 → $113
Current: $58.86
Upside: +91.98%
89bio
Jan 31, 2025
Maintains: Buy
Price Target: $25 → $38
Current: $7.71
Upside: +393.19%
Akero Therapeutics
Jan 31, 2025
Maintains: Buy
Price Target: $42 → $109
Current: $39.85
Upside: +173.53%
Zentalis Pharmaceuticals
Jan 28, 2025
Maintains: Neutral
Price Target: $5 → $2.2
Current: $1.23
Upside: +78.86%
Revolution Medicines
Jan 8, 2025
Maintains: Buy
Price Target: $65 → $71
Current: $40.42
Upside: +75.66%
Jan 7, 2025
Initiates: Buy
Price Target: $196
Current: $151.46
Upside: +29.41%
Jan 7, 2025
Initiates: Buy
Price Target: $28
Current: $10.10
Upside: +177.23%
Nov 12, 2024
Initiates: Buy
Price Target: $12
Current: $3.26
Upside: +268.10%
Nov 12, 2024
Initiates: Neutral
Price Target: $3
Current: $3.62
Upside: -17.13%
Nov 12, 2024
Initiates: Buy
Price Target: $26
Current: $5.59
Upside: +365.12%
Nov 4, 2024
Maintains: Buy
Price Target: $80 → $74
Current: $30.07
Upside: +146.09%
Oct 30, 2024
Maintains: Neutral
Price Target: $23 → $33
Current: $19.62
Upside: +68.20%
Sep 18, 2024
Maintains: Neutral
Price Target: $97 → $131
Current: $92.87
Upside: +41.06%
Sep 9, 2024
Maintains: Neutral
Price Target: $10 → $2
Current: $0.75
Upside: +165.43%
Jun 28, 2024
Maintains: Buy
Price Target: $253 → $288
Current: $251.15
Upside: +14.67%
Apr 4, 2024
Maintains: Neutral
Price Target: $3 → $5
Current: $3.77
Upside: +32.63%
Mar 27, 2024
Maintains: Buy
Price Target: $19 → $18
Current: $3.04
Upside: +492.11%
May 19, 2023
Maintains: Buy
Price Target: $45 → $42
Current: $12.79
Upside: +228.38%
Dec 7, 2022
Maintains: Buy
Price Target: $19 → $8
Current: $1.11
Upside: +620.72%
Oct 13, 2022
Initiates: Buy
Price Target: $22
Current: $4.09
Upside: +437.90%
Jun 23, 2022
Maintains: Buy
Price Target: $51 → $47
Current: $7.52
Upside: +525.00%
May 21, 2021
Initiates: Buy
Price Target: $16
Current: $5.99
Upside: +167.34%
May 21, 2021
Initiates: Buy
Price Target: $123
Current: $6.61
Upside: +1,760.82%
Aug 19, 2020
Maintains: Neutral
Price Target: $192 → $134
Current: $25.31
Upside: +429.44%